South Asians With Type 2 Diabetes at Risk for Depression

This study is looking at a special program for South Asian adults with Type 2 Diabetes (T2D) who might also be at risk for depression. The program, called CHW-led T2D Intervention, uses community health workers and includes mental health and digital tools. The goal is to see if this program can help improve blood sugar levels (HbA1c), reduce feelings of diabetes distress, and lessen symptoms of depression. You might be able to join if you are a South Asian adult between 18 and 75 years old, live in NYC, and have T2D. The study plans to enroll 100 people, but its current status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific program. It plans to enroll 100 participants.
What's involved
The study measures changes in your HbA1c levels, Diabetes Distress Scale score, and Patient Health Questionnaire-9 score at the start and again at Month 3.
Compensation
Not stated in the trial record.
Follow-up
Your progress will be checked at Month 3 after starting the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07219667

South Asians With Type 2 Diabetes at Risk for Depression

Not Yet Recruiting
NAAges 18–75InterventionalHealth services
NYU Langone Health
~100 participants
Updated 2026-05-19 on ClinicalTrials.gov
What's tested:CHW-led T2D Intervention

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in HbA1c Levels
Measured over Baseline, Month 3
+2 more outcomes measured
Type 2 Diabetes
1 sites across 1 states
New York1
  • Naheed Ahmed, PhD · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

South Asian ethnicity based on self-report information
18 years of age or older
Residing in NYC
Willingness and capacity to provide consent
South Asian ethnicity based on patient demographic information
18 to 75 years of age
Appointment for routine non-emergent primary care in the past 12 months
Diagnosis of Type 2 diabetes
Patient Health Questionnaire-9 (PHQ-9) score of ≥5 (mild to severe depression)
Residing in NYC
Willingness and capacity to provide consent

Exclusion

Pregnant at the time of screening
Type 1 diabetes or diabetes secondary to other conditions (e.g., steroid-induced, pancreatic insufficiency)
Malignancy or life-threatening illness with a life expectancy of \<5 years
Inability to perform unsupervised physical activity
Diagnosed cognitive deficits or limited decision-making capacity
Currently taking anti-depressant medication or receiving counseling services.
  • Change in HbA1c LevelsBaseline, Month 3

    Change in glycated hemoglobin (HbA1c).

  • Change in Diabetes Distress Scale (DDS) ScoreBaseline, Month 3

    The Diabetes Distress Scale (DDS) is a 17-item psychological questionnaire designed to assess the emotional and psychological distress experienced by individuals with diabetes. Each item is rated on a scale of 0 to 6. The total score is calculated by summing up the scores of all 17 items and ranges from 0-102; higher scores indicate greater distress.

  • Change in Patient Health Questionnaire-9 (PHQ-9) ScoreBaseline, Month 3

    The PHQ-9 is a 9-item questionnaire to assess depressive symptoms. Each item is scored from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27. Higher scores indicate greater severity of depression.